ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Tevimbra, 100 mg / 10 ml Konzentrat zur Herstellung einer Infusionslösung - 
68960001 BeiGene Switzerland GmbH
Tevimbra, 100 mg / 10 ml Konzentrat zur Herstellung einer Infusionslösung11.04.2024
  11.04.2024
(L01FF09) 
WHO-DDD10.04.2029
 
07.16.10. 
A  
No 
IP 
PR  
k.A.PR
  
7680689600017Biotechnologika
  
Composition
tislelizumabum 100 mg, natrii citras dihydricus, acidum citricum monohydricum, histidini hydrochloridum monohydricum, histidinum, trehalosum dihydricum, polysorbatum 20, aqua ad iniectabile q.s. ad solutionem pro 10 ml corresp. natrium 16 mg.
Packungsbestandteile
 
 
Active AgentDose
Tislelizumabum100mg / 10ml
 
Inactive agents
Citric Acid Monohydrate
Histidin Hydrochloride Monohydrate
Histidine
Natrii Citras Dihydricus
Polysorbatum 20
Trehalosum Dihydricum
Source
Data was imported : 04.05.2024 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2024 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home